VEGFA and angiosarcoma: The transcription factor p53 and its main inhibitor MDM2 were linked to development of angiosarcomas both on an animal model [27,28] and in patients with BA, also associated with upregulation of vascular endothelial growing factor (VEGF) expression [29,30,31].